Provided are 5-substituted quinazolinone compounds, for example, of formula (I), and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use for treating angiogenesis or cytokine related disorders, and pharmaceutical compositions of these compounds are disclosed. ##STR00001##

 
Web www.patentalert.com

< Agents for Reversing Epigenetic Silencing of Genes

> SPIRO-RING COMPOUND

> Pyrazolonaphthyridine derivatives

~ 00598